BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3990334)

  • 1. Acute undifferentiated leukemia: induction of partial differentiation by phorbol ester.
    Shkolnik T; Schlossman SF; Griffin JD
    Leuk Res; 1985; 9(1):11-7. PubMed ID: 3990334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody MCS-2 as the marker of phorbol diester-induced myeloid differentiation in acute undifferentiated leukemia.
    Gregg SL; Gajl-Peczalska KJ; LeBien TW; Bloomfield CD; Brunning R; Sagawa K
    Cancer Res; 1984 Jun; 44(6):2724-30. PubMed ID: 6372996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological analysis of cell surface antigens of HL-60 cells before and after treatment with a phorbol ester tumor promoter.
    Namikawa R; Ogata S; Ueda R; Tsuge I; Nishida K; Minami S; Koike K; Suchi T; Ota K; Iijima S; Takahashi T
    Leuk Res; 1983; 7(3):375-87. PubMed ID: 6604202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.
    Griffin JD; Davis R; Nelson DA; Davey FR; Mayer RJ; Schiffer C; McIntyre OR; Bloomfield CD
    Blood; 1986 Dec; 68(6):1232-41. PubMed ID: 2946331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies.
    Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J
    J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of human leukemias in response to 12-0-tetradecanoylphorbol-13-acetate in vitro.
    Pegoraro L; Abrahm J; Cooper RA; Levis A; Lange B; Meo P; Rovera G
    Blood; 1980 May; 55(5):859-62. PubMed ID: 6928789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
    Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
    Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of myeloid differentiation antigens on normal and malignant myeloid cells.
    Griffin JD; Ritz J; Nadler LM; Schlossman SF
    J Clin Invest; 1981 Oct; 68(4):932-41. PubMed ID: 6945311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
    Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
    J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induction of differentiation of human myelomonocytic cell lines by chemical inducers: analysis of surface antigens with monoclonal antibodies].
    Yamada K; Okabe N; Saito H; Suzuki R
    Nihon Ketsueki Gakkai Zasshi; 1984 May; 47(3):703-8. PubMed ID: 6591672
    [No Abstract]   [Full Text] [Related]  

  • 11. Surface markers in acute non-lymphoid leukemia: analysis with a panel of 36 monoclonal antibodies.
    Campos L; Guyotat D; Gentilhomme O; Treille D; Archimbaud E; Fiere D; Germain D
    Blut; 1987 Feb; 54(2):65-71. PubMed ID: 3814828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of differentiation of human myeloid leukemias by phorbol diesters: phenotypic changes and mode of action.
    Rovera G; Ferrero D; Pagliardi GL; Vartikar J; Pessano S; Bottero L; Abraham S; Lebman D
    Ann N Y Acad Sci; 1982 Dec; 397():211-20. PubMed ID: 6961843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undifferentiated leukemia of infancy with t(11:17) chromosomal rearrangement. Coexpressing myeloid and B cell restricted antigens.
    Umiel T; Nadler LM; Cohen IJ; Levine H; Stark B; Mammon Z; Dzaldetti M; Rechavi G; Simoni F; Katzir N
    Cancer; 1987 Mar; 59(6):1143-9. PubMed ID: 3102033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro induction of myeloid surface markers in a rare case of acute leukemia.
    Drexler HG; Coustan-Smith E; Gignac SM; Jani H; Hoffbrand AV
    Am J Hematol; 1987 Aug; 25(4):441-8. PubMed ID: 3303919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia, FAB M-1 microgranular variant: a multiparameter study.
    Nguyen D; Brynes RK; Macaulay L; Kaplan B; Pinter-Brown LC
    Hematol Pathol; 1989; 3(1):11-22. PubMed ID: 2545666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation-associated changes in human non-T, non-B leukemia cell lines after treatment with 12-O-tetradecanoylphorbol 13-acetate (TPA).
    Sakagami H; Ozer H; Minowada J; Takeda K; Bloch A
    Leuk Res; 1984; 8(2):187-95. PubMed ID: 6717062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
    Stöckbauer P; Malasková V; Soucek J; Chudomel V
    Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of phorbol-ester-induced adhesion of differentiating human myeloid leukemic cells by pentamidine-isethionate.
    Klemes Y; Kidron M; Mayer M; Fibach E
    Differentiation; 1984; 27(2):141-5. PubMed ID: 6383928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory leukemic B cells express T cell markers in vitro. A phenomenon suppressed by TPA.
    Efremidis AP; Haubenstock HS; Papadopoulos NM; Holland JF; Bekesi JG
    J Immunopharmacol; 1986; 8(2):129-44. PubMed ID: 3487592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol ester-induced differentiation of human T-lymphoblastic cell line HPB-ALL.
    Nakao Y; Matsuda S; Fujita T; Watanabe S; Morikawa S; Saida T; Ito Y
    Cancer Res; 1982 Sep; 42(9):3843-50. PubMed ID: 6179612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.